Delivery Order SPE2DR25D9206-SPE2DR26FRBV5
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,113.52 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in one-dose vials. The award, issued on November 3, 2025, with an ultimate completion date of November 25, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating the contractor competed in an unrestricted...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,135.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of YF-VAX (Yellow Fever Vaccine) in 1-dose vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of December 10, 2025, and was awarded on November 18, 2025, with no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,113.54 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in single-dose vials. The delivery order, issued on December 6, 2025, with an ultimate completion date of December 29, 2025, utilizes firm fixed-price pricing with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a $13,919 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in one-dose vial format. The delivery order, issued on December 1, 2025, with an ultimate completion date of December 22, 2025, carries no set-aside designation, indicating the vendor competed against other contractors in unrestricted federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,783.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of YF-VAX (Yellow Fever Vaccine) in 1-dose vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of December 18, 2025, and was issued without a set-aside designation, demonstrating the contractor's competitive capability in...
- The Defense Logistics Agency awarded a $27,835.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in one-dose vial format. The delivery order was issued on October 16, 2025, with an ultimate completion date of November 6, 2025, and carries no set-aside designation, indicating DMS Pharmaceutical Group competed successfully in unrestricted...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,340.56 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in one-dose vials. The contract, designated as a firm fixed-price delivery order with no set-aside designation, is scheduled for completion by November 28, 2025, and was awarded on November 5, 2025. DMS Pharmaceutical Group serves as the prime...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,135.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for Yellow Fever vaccine (YF-VAX) vials. The award, issued on November 26, 2025, with an ultimate completion date of December 18, 2025, utilizes firm fixed-price delivery order terms under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. No set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $1,113.52 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in single-dose vials. The delivery order, issued on November 10, 2025, with an ultimate completion date of December 3, 2025, carries firm fixed-price terms and received no set-aside designation, demonstrating the contractor's competitive capability in unrestricted...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,670.28 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in one-dose vial format. The delivery order, issued on December 4, 2025, with an ultimate completion date of December 26, 2025, was awarded without a set-aside designation, demonstrating DMS Pharmaceutical Group's competitive capability in unrestricted...
- SPE2DR25D9206Indefinite Delivery Contract
- SPE2DR25D9206-SPE2DR26FRBV5Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,135.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in one-dose vials. The award was issued on December 8, 2025, with an ultimate completion date of December 30, 2025, under a firm fixed-price delivery order contract with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA, designated as contract SPE2DR under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded on November 13, 2025, with a $499,999,999 ceiling value and completion date of December 31, 2036. The PPV-G GEN V represents a $30.3 billion federal acquisition strategy designed to ensure consistent pharmaceutical supply to Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical Group, as a single-award prime vendor contractor, is positioned to supply a comprehensive range of pharmaceutical products including branded and generic prescription medications, biologics, vaccines, and medical consumables to support recurring DoD medical supply needs. The company maintains no identified subcontractor relationships and has demonstrated substantial federal contracting capability through numerous prior delivery orders, establishing its role as a critical supplier within the federal military pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.1k | 12/7/25 |